Pharmacogenetics & Stratified Medicine Network

Company Description

The UK Pharmacogenetics and Stratified Medicine Network is dedicated to developing collaborative partnerships between healthcare professionals, academic researchers, industry partners, regulatory bodies and patients to synergise research into stratified medicine across the UK and support its adoption into the clinic.

Academic and clinical research has revealed that most diseases have multiple subtypes that require different treatment approaches. 

Stratified medicine (also described as personalised, precision, or P4, Predictive, Preventive, Personalized and Participatory medicine) uses technical advances in genetic sequencing techniques, along with bespoke diagnostic tests, to prescribe the drug that is most likely to have a positive therapeutic effect for patients, from the start of their treatment, at the optimum dose and in the right combination with other medication.

Prescribing patients their treatment based on their genetic profile, molecular basis of their disease, risk of disease, and response to a particular drug therapy, rather than the signs or symptoms of their disease, improves healthcare outcome.